(10.06.2021)
Although the new vaccine variants shows considerable promise, Prof Gilbert said there was no guarantee it would be mass-produced since existing jabs are proving effective against new strains – so it may make more sense to carry on producing those rather than manufacturing different ones.
(10.06.2021)
Although the new vaccine variants shows considerable promise, Prof Gilbert said there was no guarantee it would be mass-produced since existing jabs are proving effective against new strains – so it may make more sense to carry on producing those rather than manufacturing different ones.
(16.03.2021)
The objective of Global Britain is not to swagger or strike attitudes on the world stage. It is to use the full spectrum of our abilities, now amplified by record spending on both defence and science, to engage with and help the rest of the world. That is how we serve the British interest, and I mean the economic interest of people up and down the country. And as the vaccine programme begins to inspire a new global hope, we want to use this moment to heal, both literally and figuratively.
(23 November 2020)
The virus from chimps is genetically modified so it cannot cause an infection in people. It can then be modified again to contain the genetic blueprints for whatever you want to train the immune system to attack. This target is known is an antigen.
ChAdOx1 is in essence a sophisticated, microscopic postman. All the scientists have to do is change the package.
„We drop it in and off we go,“ said Prof Gilbert.
(23 November 2020)
The virus from chimps is genetically modified so it cannot cause an infection in people. It can then be modified again to contain the genetic blueprints for whatever you want to train the immune system to attack. This target is known is an antigen.
ChAdOx1 is in essence a sophisticated, microscopic postman. All the scientists have to do is change the package.
„We drop it in and off we go,“ said Prof Gilbert.
(10.06.2021)
Although the new vaccine variants shows considerable promise, Prof Gilbert said there was no guarantee it would be mass-produced since existing jabs are proving effective against new strains – so it may make more sense to carry on producing those rather than manufacturing different ones.
Professor Gilbert earlier told the BBC‘s Andrew Marr Show that her team currently has ‚a version with the South African spike sequence in the works‘ with hopes it will be ready to administer by the autumn.
‚It‘s not quite ready to vaccinate people with yet, but, as all of the developers are using platform technologies, these are ways of making a vaccine that are very quick to adapt,‘ she added.